Schedule 13G ownership disclosure

CEREVEL THERAPEUTICS HLDNG I

Security class unavailable · CUSIP: 15678U128

Event date: 2021-05-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,233,333
Percent of class
1.7500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-21-000653
Form type
SC 13G/A
Filer
Cerevel Therapeutics Holdings, Inc.
CIK
CIK 1805387
Filed
Jun 10, 2021
Reporting period
May 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub